Introduction: Acute bronchiolitis is a condition where patients are presenting with breathing difficulties, cough, poor feeding, and irritability. Treatment of bronchiolitis have many controversies. Most trials of bronchiolitis treatment suffer from 2 constraints: possible inclusion of patients with asthma and inconsistent outcome measures. The aim of the study was to determine the efficacy of prednisolone in recovery from acute bronchiolitis who have a family history of atopy. Material & Methods: This randomized double blind placebo controlled trial (RCT) was conducted in the department of pediatrics Dhaka Medical College Hospital (DMCH) from July 2008 to June 2010. Sixty (60) bronchiolitis patients having family history of atopy were included in his study. Prednisolone and placebo were packaged in identical envelops with separate code number given by the guide and the code number were recorded in a preformed questionnaire. The trial was so planned that neither the parents nor the investigator were aware of group allocation. The collected data were analyzed thoroughly by SPSS program version of 16.0 software. Informed written consent from parents or legal guardians was taken and ethical clearance was obtained from the ethical review committee of Dhaka Medical College to conduct the research works. Results: In our study, mean age of the patients of this series were 3.68 months (±1.29SD) and 3.52 month’s (±1.1SD) in prednisolone and placebo group respectively. Use of accessory muscle score was assessed twice at 8 am and 8 pm each day for three days. On first assessment at day 1 the score was similar in both the treatment groups (P>.05). More people in Prednisolone arm recovered within 3 days then the placebo group. The difference is statistically significant (P<.01). Conclusion: Three-day oral prednisolone treatment was effective in accelerating clinical recovery (Fast breathing, use of accessory muscle, wheezing) in acute bronchiolitis cases who had family history of atopy.
| Published in | American Journal of Pediatrics (Volume 7, Issue 2) |
| DOI | 10.11648/j.ajp.20210702.19 |
| Page(s) | 85-90 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Prednisolone, Placebo, Atopy, Bronchiolitis, Respiratory
| [1] | Paediatric Society of New Zealand. Wheeze and chest infection in infants under 1 year. Wellington: The Society; 2005. [Cited22August2006]. |
| [2] | Papadopoulos NG, Moustaki M, Tsolia M, Bossios A, Astra E, Prezerakou A, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med 2002; 165: 1285-89? |
| [3] | Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140 (6): 543-6. |
| [4] | ISD Scotland. Number of hospital discharges with bronchiolitis in children 0-24 months in Scotland for the years ending December 2001 - 2003. [Statistical data]. Edinburgh: ISD Scotland; 2006. |
| [5] | Josephine R. Welliver and Robert C. Welliver. Bronchiolitis. Pediatr. Rev. 1993; 14; 134-139. |
| [6] | Pullan CR, Hey EN - Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Brit Med J 1982; 284: 1665-9. |
| [7] | Sims DG, Gardner PS, Weightman D et al. - Atopy does not predispose to RSV bronchiolitis or postbronchiolitic wheezing. Brit Med J 1981; 282: 2086-88. |
| [8] | Ehlenfield DR, Cameron K, Welliver RC - Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics 2000; 105: 79-83. |
| [9] | Csonka P, Kaila M, Laipapala P, Iso Mustajardi M, Vesikari T, Ashorn P. Oral prednisolone in the acute management of children age 6-35 months with viral infection induced lower airway disease: a randomized placebo - controlled trial. J Pediatr 2003; 143 (6): 700-702. |
| [10] | Kuyucu S, Unal S, Kuyucu N, Yilgor E. Additive effects of dexamethasone in nebulized salbutamol or L - epinephrine treated infants with ac. Bronchiolitis. Pediatr int. 2004; 46 (5): 539-544. |
| [11] | Kabir ARML, Amin R, Morsed AKMA, Shirin M. update on a recent epidemic. The Orion 2002; 12: 9-10. |
| [12] | Sayeed A. Efficacy of oral prednisolone in the treatment of acute bronchiolitis: A randomized control trial [Dissertation]. Dhaka: BCPS; 2005. |
| [13] | Smyth A, Carty H, Hart CA. Clinical predictors of hypoxemia in children with pneumonia. Ann Trop Pediatr 1998; 18: 31-40. |
| [14] | Klassen TP, Sutcliff T, Watters LK, Wells GA, Alien UD, Li MM. Dexamethasone in salbutamol-treated in patients with acute bronchiolitis: a randomized, controlled trial. J Pediatr 1997; 130: 191-196. |
| [15] | Van Woensel JB, Wolfs TF, van Alderen WM, Brand PL, Kimpen JL Randomized double-blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax 1997; 52: 634-637. |
| [16] | Noble V, Murray M, Webb MSC, Alexander J, Swarbrick AS, Milner AD Respiratory status and allergy nine to ten years after acute bronchiolitis. Arch Dis Child 1997; 76: 315-319. |
| [17] | Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM, Group Health Medical Associates Personnel Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319: 112-117. |
| [18] | Patel H, Platt R, Lozano JM, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children (Cochran Review). In: The Cochrane Library, issue 3. Chichester, UK: John Wiley & Sons; 2004. |
| [19] | Asthma Association, Bangladesh. National Guidelines Asthma, Bronchiolitis, COPD. 3rd Edition. 2005. |
APA Style
Khondaker Zahirul Hasan, Md. Abid Hossain Mollah, Mohammad Monir Hossain, Muhammad Zahangir Alam, A. N. M. Shahidul Islam Bhuiyan, et al. (2021). Efficacy of Prednisolone in Recovery from Acute Bronchiolitis: Study in a Tertiary Care Hospital, Dhaka, Bangladesh. American Journal of Pediatrics, 7(2), 85-90. https://doi.org/10.11648/j.ajp.20210702.19
ACS Style
Khondaker Zahirul Hasan; Md. Abid Hossain Mollah; Mohammad Monir Hossain; Muhammad Zahangir Alam; A. N. M. Shahidul Islam Bhuiyan, et al. Efficacy of Prednisolone in Recovery from Acute Bronchiolitis: Study in a Tertiary Care Hospital, Dhaka, Bangladesh. Am. J. Pediatr. 2021, 7(2), 85-90. doi: 10.11648/j.ajp.20210702.19
AMA Style
Khondaker Zahirul Hasan, Md. Abid Hossain Mollah, Mohammad Monir Hossain, Muhammad Zahangir Alam, A. N. M. Shahidul Islam Bhuiyan, et al. Efficacy of Prednisolone in Recovery from Acute Bronchiolitis: Study in a Tertiary Care Hospital, Dhaka, Bangladesh. Am J Pediatr. 2021;7(2):85-90. doi: 10.11648/j.ajp.20210702.19
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajp.20210702.19,
author = {Khondaker Zahirul Hasan and Md. Abid Hossain Mollah and Mohammad Monir Hossain and Muhammad Zahangir Alam and A. N. M. Shahidul Islam Bhuiyan and Md. Faruk Ahmed and Md. Iftekhar-ul-Haque Khan},
title = {Efficacy of Prednisolone in Recovery from Acute Bronchiolitis: Study in a Tertiary Care Hospital, Dhaka, Bangladesh},
journal = {American Journal of Pediatrics},
volume = {7},
number = {2},
pages = {85-90},
doi = {10.11648/j.ajp.20210702.19},
url = {https://doi.org/10.11648/j.ajp.20210702.19},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20210702.19},
abstract = {Introduction: Acute bronchiolitis is a condition where patients are presenting with breathing difficulties, cough, poor feeding, and irritability. Treatment of bronchiolitis have many controversies. Most trials of bronchiolitis treatment suffer from 2 constraints: possible inclusion of patients with asthma and inconsistent outcome measures. The aim of the study was to determine the efficacy of prednisolone in recovery from acute bronchiolitis who have a family history of atopy. Material & Methods: This randomized double blind placebo controlled trial (RCT) was conducted in the department of pediatrics Dhaka Medical College Hospital (DMCH) from July 2008 to June 2010. Sixty (60) bronchiolitis patients having family history of atopy were included in his study. Prednisolone and placebo were packaged in identical envelops with separate code number given by the guide and the code number were recorded in a preformed questionnaire. The trial was so planned that neither the parents nor the investigator were aware of group allocation. The collected data were analyzed thoroughly by SPSS program version of 16.0 software. Informed written consent from parents or legal guardians was taken and ethical clearance was obtained from the ethical review committee of Dhaka Medical College to conduct the research works. Results: In our study, mean age of the patients of this series were 3.68 months (±1.29SD) and 3.52 month’s (±1.1SD) in prednisolone and placebo group respectively. Use of accessory muscle score was assessed twice at 8 am and 8 pm each day for three days. On first assessment at day 1 the score was similar in both the treatment groups (P>.05). More people in Prednisolone arm recovered within 3 days then the placebo group. The difference is statistically significant (PConclusion: Three-day oral prednisolone treatment was effective in accelerating clinical recovery (Fast breathing, use of accessory muscle, wheezing) in acute bronchiolitis cases who had family history of atopy.},
year = {2021}
}
TY - JOUR T1 - Efficacy of Prednisolone in Recovery from Acute Bronchiolitis: Study in a Tertiary Care Hospital, Dhaka, Bangladesh AU - Khondaker Zahirul Hasan AU - Md. Abid Hossain Mollah AU - Mohammad Monir Hossain AU - Muhammad Zahangir Alam AU - A. N. M. Shahidul Islam Bhuiyan AU - Md. Faruk Ahmed AU - Md. Iftekhar-ul-Haque Khan Y1 - 2021/06/04 PY - 2021 N1 - https://doi.org/10.11648/j.ajp.20210702.19 DO - 10.11648/j.ajp.20210702.19 T2 - American Journal of Pediatrics JF - American Journal of Pediatrics JO - American Journal of Pediatrics SP - 85 EP - 90 PB - Science Publishing Group SN - 2472-0909 UR - https://doi.org/10.11648/j.ajp.20210702.19 AB - Introduction: Acute bronchiolitis is a condition where patients are presenting with breathing difficulties, cough, poor feeding, and irritability. Treatment of bronchiolitis have many controversies. Most trials of bronchiolitis treatment suffer from 2 constraints: possible inclusion of patients with asthma and inconsistent outcome measures. The aim of the study was to determine the efficacy of prednisolone in recovery from acute bronchiolitis who have a family history of atopy. Material & Methods: This randomized double blind placebo controlled trial (RCT) was conducted in the department of pediatrics Dhaka Medical College Hospital (DMCH) from July 2008 to June 2010. Sixty (60) bronchiolitis patients having family history of atopy were included in his study. Prednisolone and placebo were packaged in identical envelops with separate code number given by the guide and the code number were recorded in a preformed questionnaire. The trial was so planned that neither the parents nor the investigator were aware of group allocation. The collected data were analyzed thoroughly by SPSS program version of 16.0 software. Informed written consent from parents or legal guardians was taken and ethical clearance was obtained from the ethical review committee of Dhaka Medical College to conduct the research works. Results: In our study, mean age of the patients of this series were 3.68 months (±1.29SD) and 3.52 month’s (±1.1SD) in prednisolone and placebo group respectively. Use of accessory muscle score was assessed twice at 8 am and 8 pm each day for three days. On first assessment at day 1 the score was similar in both the treatment groups (P>.05). More people in Prednisolone arm recovered within 3 days then the placebo group. The difference is statistically significant (PConclusion: Three-day oral prednisolone treatment was effective in accelerating clinical recovery (Fast breathing, use of accessory muscle, wheezing) in acute bronchiolitis cases who had family history of atopy. VL - 7 IS - 2 ER -
Information
Email: